Introductory Offer
Save up to 50% on your first RNA-Seq project with Lexogen NGS Services!
Does your project tick all the boxes?
≥ 48 samples
Whole Transcriptome Sequencing (with polyA selection or rRNA depletion)
For new customers only
Compatible with low-input (<10 ng) and low quality (RIN<5) RNA
Ideal for FFPE, blood, animal, plant, environmental or mixed samples
Samples at our facility before the end of October 2025
Is your project a fit? Fill out the form to receive your introductory offer!
Terms & Conditions
-
This promotion is run by Lexogen GmbH (hereafter referred to as “Lexogen”) and shall exclusively be governed by the Terms and Conditions below and by “General Terms and Conditions of Sales of Lexogen GmbH” in the version respectively in effect at the time of the conclusion of each contract. The current version of the General Terms and Conditions of Sales of Lexogen GmbH is available at www.lexogen.com/terms-and-conditions or can be requested free of charge at info@lexogen.com.
-
This special offer is valid until September 30th, 2025 (Purchase Order income). Samples need to be delivered to Lexogen’s NGS Service facility by October 31st, 2025.
-
Only Service requests are eligible for the special offer that are submitted within the promotion period. Existing service projects and re-submissions of previous requests are excluded.
-
The promotion covers the preparation of Whole Transcriptome libraries (with prior polyA selection or rRNA depletion) and SR or PE sequencing (on average 20 M reads/ sample) of 48 samples or more. RNA extraction, spike-in controls (SIRVs), and data analysis are not included but are available at extra costs.
-
Requests can be directed to Lexogen by using the form above or by e-mailing to services@lexogen.com.
-
This introductory offer applies to new customers only and cannot be combined with other offerings.
-
Terms and conditions are subject to change at any time without notice. Other restrictions may apply.
-
These General Terms and Conditions of Sales of Lexogen GmbH shall be subject to and construed in accordance with Austrian law.
“We have evaluated a double depletion method along with poly(A) capture using the CORALL RNA-Seq kit on isolated RNA from human blood collected in PAXgene tubes [...]. The workflow of using poly(A) selection combined with RiboCop HMR plus Globin and CORALL RNA-Seq library preparation was smooth and user-friendly and is highly recommended from a lab perspective.”
“Throughout my career, leading genomic projects and departments, I have always been a fan of Lexogen chemistry. When I finally decided to co-found a genomics company, I was delighted to hear that Lexogen had a services arm, and signed up immediately. We work with extremely challenging samples, from biobanked FFPEs to micro-organ samples. At every step Lexogen has worked closely with us, even helping to optimise our protocols, to ensure the best possible results.”
About Lexogen
Lexogen is a biotech company focusing on RNA and complete transcriptome studies using next generation sequencing technologies.
We have been at the forefront of RNA research since 2007, and our technologies and products are being used by thousands of scientists all over the world. “Lexo” in Greek means “word”, and Lexogen stands for the word of genes, which is the transcriptome. We strive to be the pioneers in this fascinating field of RNA science, and together with the fastest-growing technology of the past years, the next generation sequencing (NGS), we are sure that we can make a big contribution to the world.
Email
info@lexogen.com
Telephone:
US +1-603-431-4300
Rest of the world +43 (0) 1 345 1212
Lexogen ISO certifications
We proudly hold both ISO 9001 and ISO 13485 certifications, which not only demonstrate our drive for innovation but also our unwavering devotion to delivering reliable, robust, and cutting-edge solutions to our valued customers.
